Certolizumab-induced guttate psoriasiform dermatitis.
Certolizumab is a TNF inhibitor that has showngreat efficacy in chronic inflammatory diseases. Wereport a patient exhibiting a novel adverse effect ofcertolizumab: drug-induced guttate psoriasiformeruption. A review of the mechanism of psoriasiformdrug eruptions is also included.
Division of Dermatology, University of Kansas Medical Center, Kansas City. ryanfischeruk@gmail.com.
Ryan
R
Fischer
Matthew
M
DaCunha
Anand
A
Rajpara
D000328:Adult; D000068582:Certolizumab Pegol / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000139:chemically induced* / Q000473:pathology
D007166:Immunosuppressive Agents; D000068582:Certolizumab Pegol